Related Experiment Video

Updated: Jul 6, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Methods of telomerase inhibition

Lucy G Andrews1, Trygve O Tollefsbol

  • 1Department of Biology, University of Alabama at Birmingham, Birmingham, AL, USA.

Methods in Molecular Biology (Clifton, N.J.)
|March 29, 2008
PubMed

Insights

Telomerase inhibition is a promising anticancer strategy. Research focuses on targeting telomerase components like telomerase reverse transcriptase (TERT) and telomerase RNA (TR), or associated proteins such as tankyrase, to combat cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Telomerase is crucial for cellular immortality.
  • It is highly expressed in most cancer cells but not in normal cells.
  • This makes telomerase a significant target for cancer therapy.

Purpose of the Study:

  • To summarize recent advancements in telomerase inhibition strategies.
  • To explore different approaches for targeting telomerase as an anticancer strategy.

Main Methods:

  • Focusing on inhibiting the telomerase ribonucleoprotein holoenzyme.
  • Targeting the telomerase reverse transcriptase (TERT) catalytic subunit.
  • Targeting the telomerase RNA (TR) component.
  • Developing protocols to inhibit associated proteins like tankyrase.

Main Results:

  • Several methods for telomerase inhibition have been developed.
  • These methods target key components of the telomerase complex.
  • Advances include targeting TERT, TR, and associated proteins.

Conclusions:

  • Telomerase inhibition represents a viable anticancer approach.
  • Targeting telomerase components (TERT, TR) and associated proteins (tankyrase) are key strategies.
  • Continued research in this area holds significant therapeutic potential.

More Related Videos

In vitro Reconstitution of the Active T. castaneum Telomerase09:25

In vitro Reconstitution of the Active T. castaneum Telomerase

Published on: July 14, 2011

Semi-quantitative Detection of RNA-dependent RNA Polymerase Activity of Human Telomerase Reverse Transcriptase Protein08:26

Semi-quantitative Detection of RNA-dependent RNA Polymerase Activity of Human Telomerase Reverse Transcriptase Protein

Published on: June 12, 2018

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.